About FSOSX
Fidelity Series Overseas Fund is a mutual fund focused on seeking long-term capital growth by investing primarily in non-U.S. equities. The fund typically allocates at least 80% of its assets in securities of companies located outside the United States, targeting developed international markets with a strong emphasis on large-cap growth stocks. Its portfolio often features leading global firms in sectors such as technology, healthcare, industrials, and consumer cyclical, with significant holdings in countries like the United Kingdom, Japan, France, and Germany. Notable portfolio positions include prominent companies such as ASML Holding, Novo Nordisk, SAP, and AstraZeneca.
This fund serves as a core international equity component within multi-asset portfolios, notably acting as an underlying investment for Fidelity Freedom Funds and select asset management programs, rather than being available for direct retail purchase. With a disciplined investment approach that focuses on high-quality companies able to generate sustainable returns, the fund leverages in-depth fundamental research to identify businesses trading at favorable valuations. Its low expense ratio and diversified exposure make it a strategic tool for achieving global diversification and capturing growth opportunities beyond the U.S. market.
Fund Family Fidelity
Category Foreign Large Growth
Performance Rating Above Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol FSOSX
Index Index is not available on Lipper Database
FSOSX had a total return of 9.54% in the past year, including dividends. Since the fund's
inception, the average annual return has been 9.82%.
